Open access
Open access
Powered by Google Translator Translator

Infectious Diseases

Randomized trial: Tocilizumab does not improve outcomes for patients hospitalized with Covid-19

22 Oct, 2020 | 09:42h | UTC

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19 – New England Journal of Medicine

Commentary: Tocilizumab doesn’t ease symptoms or prevent death in moderately ill COVID-19 inpatients – Massachusetts General Hospital

 


Amid pandemic, U.S. has seen 300,000 ‘excess deaths,’ with highest rates among people of color

22 Oct, 2020 | 09:41h | UTC

Amid pandemic, U.S. has seen 300,000 ‘excess deaths,’ with highest rates among people of color – STAT

Original report: Excess Deaths Associated with COVID-19, by Age and Race and Ethnicity — United States, January 26–October 3, 2020 – Centers for Disease Control and Prevention

 

Commentary on Twitter

 


Will Covid-19 vaccines save lives? Current trials aren’t designed to tell us

22 Oct, 2020 | 09:40h | UTC

Will covid-19 vaccines save lives? Current trials aren’t designed to tell us – The BMJ

Commentaries: COVID-19 vaccine trials won’t tell us if the shots save lives, expert notes – CNN AND Coronavirus vaccine trials won’t tell us if they save lives, prevent serious illness or stop transmission – here’s why – The Conversation

 

Commentary on Twitter

 


New calculator predicts risk of hospital admission and mortality from coronavirus 19 in adults

22 Oct, 2020 | 09:37h | UTC

Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study – The BMJ

See calculator: QCovid® risk calculator

 

Commentary on Twitter

 


SARS-CoV-2 immunity: Review and applications to phase 3 vaccine candidates

22 Oct, 2020 | 09:36h | UTC

SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates – The Lancet

Commentary: The COVID-19 vaccine pipeline – News Medical

 

Commentary on Twitter

 


Perspective: Immunity and Re-Infection

22 Oct, 2020 | 09:34h | UTC

Immunity and Re-Infection – Science Translational Medicine

 


Video consultations in primary and specialist care during the covid-19 pandemic and beyond

21 Oct, 2020 | 09:30h | UTC

Video consultations in primary and specialist care during the covid-19 pandemic and beyond – The BMJ

 


Studies offer little hope for Tocilizumab in treating COVID

21 Oct, 2020 | 09:27h | UTC

Studies offer little hope for tocilizumab in treating COVID – CIDRAP

See studies: Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19 – JAMA Internal Medicine AND Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial – JAMA Internal Medicine AND Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial – JAMA Internal Medicine

Commentary: expert reaction to three studies of Tocilizumab to treat COVID patients – Science Media Centre

Related study (preprint): Tocilizumab in Hospitalized Patients With COVID-19 Pneumonia – medRxiv

 


Dozens to be deliberately infected with coronavirus in UK ‘human challenge’ trials

21 Oct, 2020 | 09:25h | UTC

Dozens to be deliberately infected with coronavirus in UK ‘human challenge’ trials – Nature

Commentaries: U.K. Preparing COVID-19 Vaccine Trials That Deliberately Expose Study Subjects – NPR AND UK plan to be first to run human challenge Covid trials – BBC

 


Studies point to big drop in COVID-19 death rates

21 Oct, 2020 | 09:23h | UTC

Studies Point To Big Drop In COVID-19 Death Rates – NPR

 


‘Super antigens’ tied to mysterious COVID-19 syndrome in children

21 Oct, 2020 | 09:21h | UTC

‘Super antigens’ tied to mysterious COVID-19 syndrome in children – National Geographic

 


Viewpoint – COVID-19, children and non-communicable diseases: Translating evidence into action

21 Oct, 2020 | 09:19h | UTC

COVID-19, children and non-communicable diseases: translating evidence into action – Archives of Disease in Childhood

 

Commentary on Twitter

 


Perspective: COVID-19 in children and young people

21 Oct, 2020 | 09:17h | UTC

COVID-19 in children and young people – Science

 


Updated Guideline: Coronavirus (COVID-19) infection in pregnancy

21 Oct, 2020 | 09:16h | UTC

Coronavirus (COVID-19) Infection in Pregnancy – Royal College of Obstetricians & Gynaecologists

 


Clinical Report: Evaluation and management of the infant exposed to HIV in the US

21 Oct, 2020 | 09:09h | UTC

Evaluation and Management of the Infant Exposed to HIV in the United States – Pediatrics

Commentaries: Pediatrics Group Updates Guidelines on Managing HIV-Exposed Infants – NEJM Journal Watch AND Perinatal Exposure to HIV Requires Specialized, Coordinated Care – AJMC

 


WHO takes a position on genetically modified mosquitoes

21 Oct, 2020 | 09:02h | UTC

WHO takes a position on genetically modified mosquitoes – World Health Organization

Position Statement: Evaluation of genetically modified mosquitoes for the control of vector-borne diseases – World Health Organization

Commentary: WHO Releases a Position Statement on Genetically Modified Mosquitoes for the Control of Vector-Borne Diseases – Health Policy Watch

 


Covid-19: The global crisis — in data

20 Oct, 2020 | 01:45h | UTC

Covid-19: The global crisis — in data – Financial Times

 


Herd immunity and implications for SARS-CoV-2 control

20 Oct, 2020 | 01:44h | UTC

Herd Immunity and Implications for SARS-CoV-2 Control – JAMA

Author Interview: Can We Count on Herd Immunity to Control COVID-19? – JAMA

Patient Page: What Is Herd Immunity? – JAMA

 

Commentary on Twitter

 


Editorial: Covid-19’s known unknowns

20 Oct, 2020 | 01:42h | UTC

Covid-19’s known unknowns – The BMJ

 

Commentary on Twitter

 


Opinion: The scientific and ethical feasibility of immunity passports

20 Oct, 2020 | 01:41h | UTC

The scientific and ethical feasibility of immunity passports – The Lancet Infectious Diseases

Related: Digital ‘health passport’ trials under way to aid reopening of borders – The Guardian

 


Covid-19 vaccine protocols reveal that trials are designed to succeed

20 Oct, 2020 | 01:40h | UTC

Covid-19 Vaccine Protocols Reveal That Trials Are Designed To Succeed – Forbes

 


Perspective: All eyes on a hurdle race for a SARS-CoV-2 vaccine

20 Oct, 2020 | 01:39h | UTC

All eyes on a hurdle race for a SARS-CoV-2 vaccine – Nature

 


Antimicrobial stewardship in ICUs during the COVID-19 pandemic: back to the 90s?

20 Oct, 2020 | 01:38h | UTC

Antimicrobial stewardship in ICUs during the COVID-19 pandemic: back to the 90s? – Intensive Care Medicine

 

Commentary on Twitter

 


Meta-analysis: The association of D-dimers with mortality, intensive care unit admission or ARDS in patients hospitalized with COVID-19

20 Oct, 2020 | 01:37h | UTC

The association of D-dimers with mortality, intensive care unit admission or acute respiratory distress syndrome in patients hospitalized with coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis – Heart & Lung

 


The household secondary attack rate of SARS-CoV-2: A rapid review

20 Oct, 2020 | 01:36h | UTC

The household secondary attack rate of SARS-CoV-2: A rapid review – Clinical Infectious Diseases

 

Commentary on Twitter

 


Stay Updated in Your Specialty

 

No spam, just news.